| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.11▲ | 2.11▲ | 2.11▲ | 2.12▼ | 2.15▼ |
| MA10 | 2.11▲ | 2.11▲ | 2.13▼ | 2.14▼ | 2.19▼ |
| MA20 | 2.11▲ | 2.14▼ | 2.13▼ | 2.14▼ | 2.30▼ |
| MA50 | 2.11▲ | 2.11▲ | 2.15▼ | 2.19▼ | 3.08▼ |
| MA100 | 2.14▼ | 2.15▼ | 2.10▲ | 2.37▼ | 3.03▼ |
| MA200 | 2.12▲ | 2.11▲ | 2.17▼ | 2.87▼ | 2.39▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.004▼ | -0.002▼ | 0.004▲ | 0.022▲ |
| RSI | 60.302▲ | 47.895▼ | 47.998▼ | 47.255▼ | 41.635▼ |
| STOCH | 66.667 | 22.487 | 16.919▼ | 49.312 | 47.094 |
| WILL %R | 0.000▲ | -77.273▼ | -77.273▼ | -55.319 | -63.158 |
| CCI | 145.833▲ | -46.765 | -86.148 | 25.650 | -28.150 |
| MA | $CRDF Price Crossed Below MA(13) | Set Alert |
|
Monday, November 24, 2025 05:01 AM
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management ...
|
|
Sunday, November 23, 2025 10:00 PM
Detailed price information for Cardiff Oncology Inc (CRDF-Q) from The Globe and Mail including charting and trades.
|
|
Thursday, November 06, 2025 08:05 AM
– Announced positive data from the ongoing Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer – – Expects to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/12/25 | 2.17 | 2.21 | 2.09 | 2.11 | 411,600 |
| 04/12/25 | 2.11 | 2.19 | 2.10 | 2.16 | 420,286 |
| 03/12/25 | 2.05 | 2.15 | 2.03 | 2.13 | 837,700 |
| 02/12/25 | 2.17 | 2.19 | 2.04 | 2.04 | 955,800 |
| 01/12/25 | 2.26 | 2.26 | 2.16 | 2.17 | 472,300 |
| 28/11/25 | 2.34 | 2.34 | 2.248 | 2.28 | 338,799 |
| 26/11/25 | 2.10 | 2.37 | 2.09 | 2.34 | 1,005,100 |
| 25/11/25 | 2.10 | 2.12 | 2.07 | 2.11 | 464,200 |
| 24/11/25 | 2.03 | 2.11 | 2.03 | 2.08 | 535,500 |
| 21/11/25 | 1.96 | 2.04 | 1.90 | 2.03 | 1,234,500 |
|
|
||||
|
|
||||
|
|